Your browser doesn't support javascript.
loading
The glucose transporter 2 regulates CD8+ T cell function via environment sensing.
Fu, Hongmei; Vuononvirta, Juho; Fanti, Silvia; Bonacina, Fabrizia; D'Amati, Antonio; Wang, Guosu; Poobalasingam, Thanushiyan; Fankhaenel, Maria; Lucchesi, Davide; Coleby, Rachel; Tarussio, David; Thorens, Bernard; Hearnden, Robert J; Longhi, M Paula; Grevitt, Paul; Sheikh, Madeeha H; Solito, Egle; Godinho, Susana A; Bombardieri, Michele; Smith, David M; Cooper, Dianne; Iqbal, Asif J; Rathmell, Jeffrey C; Schaefer, Samuel; Morales, Valle; Bianchi, Katiuscia; Norata, Giuseppe Danilo; Marelli-Berg, Federica M.
Afiliação
  • Fu H; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Vuononvirta J; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Fanti S; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bonacina F; Department of Pharmacological and Biomolecular Sciences (DisFeB), Università Degli Studi di Milano, Milan, Italy.
  • D'Amati A; Section of Anatomical Pathology Department of Precision and Regenerative Medicine, University of Bari Medical School, Bari, Italy.
  • Wang G; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Poobalasingam T; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Fankhaenel M; Bart's Cancer Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Lucchesi D; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Coleby R; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Tarussio D; Faculty of Biology and Medicine, Center for Integrative Genomics, Génopode Building - UNIL Sorge, University of Lausanne, Lausanne, Switzerland.
  • Thorens B; Faculty of Biology and Medicine, Center for Integrative Genomics, Génopode Building - UNIL Sorge, University of Lausanne, Lausanne, Switzerland.
  • Hearnden RJ; Bart's Cancer Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Longhi MP; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Grevitt P; Bart's Cancer Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Sheikh MH; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Solito E; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Godinho SA; Bart's Cancer Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bombardieri M; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Smith DM; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Cambridge, UK.
  • Cooper D; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Iqbal AJ; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
  • Rathmell JC; Department of Pathology, Microbiology, and Immunology, Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Schaefer S; Department of Pathology, Microbiology, and Immunology, Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Morales V; Bart's Cancer Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bianchi K; Bart's Cancer Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Norata GD; Department of Pharmacological and Biomolecular Sciences (DisFeB), Università Degli Studi di Milano, Milan, Italy.
  • Marelli-Berg FM; William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK. f.marelli-berg@qmul.ac.uk.
Nat Metab ; 5(11): 1969-1985, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37884694
ABSTRACT
T cell activation is associated with a profound and rapid metabolic response to meet increased energy demands for cell division, differentiation and development of effector function. Glucose uptake and engagement of the glycolytic pathway are major checkpoints for this event. Here we show that the low-affinity, concentration-dependent glucose transporter 2 (Glut2) regulates the development of CD8+ T cell effector responses in mice by promoting glucose uptake, glycolysis and glucose storage. Expression of Glut2 is modulated by environmental factors including glucose and oxygen availability and extracellular acidification. Glut2 is highly expressed by circulating, recently primed T cells, allowing efficient glucose uptake and storage. In glucose-deprived inflammatory environments, Glut2 becomes downregulated, thus preventing passive loss of intracellular glucose. Mechanistically, Glut2 expression is regulated by a combination of molecular interactions involving hypoxia-inducible factor-1 alpha, galectin-9 and stomatin. Finally, we show that human T cells also rely on this glucose transporter, thus providing a potential target for therapeutic immunomodulation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Facilitadoras de Transporte de Glucose / Glucose Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Facilitadoras de Transporte de Glucose / Glucose Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article